American National Bank & Trust Sells 3,704 Shares of Johnson & Johnson $JNJ

American National Bank & Trust decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 3.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 93,860 shares of the company’s stock after selling 3,704 shares during the period. Johnson & Johnson accounts for about 1.7% of American National Bank & Trust’s holdings, making the stock its 15th largest holding. American National Bank & Trust’s holdings in Johnson & Johnson were worth $17,404,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Brighton Jones LLC increased its position in shares of Johnson & Johnson by 13.9% during the fourth quarter. Brighton Jones LLC now owns 51,876 shares of the company’s stock valued at $7,502,000 after buying an additional 6,332 shares during the period. United Bank boosted its position in Johnson & Johnson by 110.7% during the 1st quarter. United Bank now owns 9,279 shares of the company’s stock valued at $1,539,000 after acquiring an additional 4,876 shares in the last quarter. Scientech Research LLC purchased a new position in shares of Johnson & Johnson during the 1st quarter worth approximately $954,000. CTC Alternative Strategies Ltd. bought a new position in shares of Johnson & Johnson in the 1st quarter worth approximately $464,000. Finally, Sciencast Management LP purchased a new position in shares of Johnson & Johnson in the 1st quarter valued at approximately $2,582,000. 69.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on JNJ shares. Morgan Stanley upped their price target on Johnson & Johnson from $190.00 to $197.00 and gave the stock an “equal weight” rating in a research note on Friday, December 12th. Scotiabank started coverage on shares of Johnson & Johnson in a research note on Thursday, November 13th. They issued a “sector outperform” rating and a $230.00 price target for the company. Barclays lifted their price target on shares of Johnson & Johnson from $197.00 to $217.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 30th. Johnson Rice set a $190.00 price objective on shares of Johnson & Johnson and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Wells Fargo & Company raised their target price on shares of Johnson & Johnson from $212.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Four investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $212.62.

Johnson & Johnson Stock Performance

Shares of JNJ stock opened at $204.32 on Tuesday. The company has a market capitalization of $492.26 billion, a price-to-earnings ratio of 19.72, a price-to-earnings-growth ratio of 2.13 and a beta of 0.34. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.80 and a current ratio of 1.07. Johnson & Johnson has a one year low of $140.68 and a one year high of $215.18. The company’s 50-day moving average is $201.45 and its 200 day moving average is $183.45.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share (EPS) for the quarter. Johnson & Johnson had a net margin of 27.26% and a return on equity of 32.73%. The business had revenue of $24.02 billion during the quarter. Sell-side analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, February 24th. This represents a $5.20 annualized dividend and a yield of 2.5%. Johnson & Johnson’s dividend payout ratio is 50.19%.

Johnson & Johnson Company Profile

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.